A mandatory clinical decision support tool eliminated racial disparities in VTE prophylaxis prescription between black and white patients in trauma (84.5% vs 85.5%) and medicine (91.8% vs 88.0%).
Cohort (n=3,541)
Does a mandatory computerized clinical decision support tool improve the prescription of risk-appropriate VTE prophylaxis and eliminate race- and sex-based disparities in hospitalized medical and trauma patients?
Implementation of a mandatory computerized clinical decision support tool significantly improved compliance with best-practice VTE prophylaxis and eliminated pre-existing race- and sex-based prescription disparities.
BACKGROUND: All hospitalized patients should be assessed for venous thromboembolism (VTE) risk factors and prescribed appropriate prophylaxis. To improve best-practice VTE prophylaxis prescription for all hospitalized patients, we implemented a mandatory computerized clinical decision support (CCDS) tool. The tool requires completion of checklists to evaluate VTE risk factors and contraindications to pharmacological prophylaxis, and then recommends the risk-appropriate VTE prophylaxis regimen. OBJECTIVES: The objective of the study was to examine the effect of a quality improvement intervention on race-based and sex-based health care disparities across 2 distinct clinical services. RESEARCH DESIGN: This was a retrospective cohort study of a quality improvement intervention. SUBJECTS: The study included 1942 hospitalized medical patients and 1599 hospitalized adult trauma patients. MEASURES: In this study, the proportion of patients prescribed risk-appropriate, best-practice VTE prophylaxis was evaluated. RESULTS: Racial disparities existed in prescription of best-practice VTE prophylaxis in the preimplementation period between black and white patients on both the trauma (70.1% vs. 56.6%, P=0.025) and medicine (69.5% vs. 61.7%, P=0.015) services. After implementation of the CCDS tool, compliance improved for all patients, and disparities in best-practice prophylaxis prescription between black and white patients were eliminated on both services: trauma (84.5% vs. 85.5%, P=0.99) and medicine (91.8% vs. 88.0%, P=0.082). Similar findings were noted for sex disparities in the trauma cohort. CONCLUSIONS: Despite the fact that risk-appropriate prophylaxis should be prescribed equally to all hospitalized patients regardless of race and sex, practice varied widely before our quality improvement intervention. Our CCDS tool eliminated racial disparities in VTE prophylaxis prescription across 2 distinct clinical services. Health information technology approaches to care standardization are effective to eliminate health care disparities.
Lau et al. (Thu,) conducted a cohort in Hospitalized medical and trauma patients (n=3,541). Mandatory computerized clinical decision support (CCDS) tool vs. Preimplementation period was evaluated on Proportion of patients prescribed risk-appropriate, best-practice VTE prophylaxis. A mandatory clinical decision support tool eliminated racial disparities in VTE prophylaxis prescription between black and white patients in trauma (84.5% vs 85.5%) and medicine (91.8% vs 88.0%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: